NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
||March 31, 2018
|Estimated average burden|
|hours per response:
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION|
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
|Commission File Number
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
||200 State Street, 13th Floor
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
|Class A Common Stock and warrant|
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
Pursuant to the requirements fo the Securities Exchange Act of 1934,
Nasdaq Stock Market LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Delisting Determination, The Nasdaq Stock Market, LLC, May 2, 2023,
Pear Therapeutics, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the Class A common stock and warrants of Pear
Therapeutics, Inc., effective at the opening of the trading session
on May 12, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101, 5110(b), and
IM-5101-1. The Company was notified of the Staff determination
on April 10, 2023. The Company did not appeal the Staff determination
to the Hearings Panel. The Company securities were suspended on
April 19, 2023. The Staff determination to delist the Company
securities became final on April 19, 2023.